Management of Subclavian Artery Stenosis
For patients with symptomatic subclavian artery stenosis, revascularization is recommended using either endovascular techniques (angioplasty with stenting) or surgical approaches (carotid-subclavian bypass), with the choice depending on patient-specific factors including surgical risk and lesion characteristics. 1
Clinical Presentation and Diagnosis
- Subclavian artery stenosis may present with upper extremity ischemia (arm claudication, paresthesia, rest pain), vertebrobasilar insufficiency symptoms (subclavian steal syndrome), or coronary subclavian steal syndrome in patients with prior CABG using internal mammary artery 1, 2
- Diagnosis can be established by:
Management Algorithm
Asymptomatic Patients
- Asymptomatic patients generally require only secondary prevention of atherosclerotic disease without specific intervention 1
- Revascularization should be considered in asymptomatic patients in specific scenarios:
- Prior to elective CABG using the ipsilateral internal mammary artery 1
- In patients who already have ipsilateral internal mammary artery grafted to coronary arteries with evidence of myocardial ischemia 1
- In patients with ipsilateral arteriovenous fistula for dialysis 1
- In patients with bilateral stenosis to enable accurate blood pressure monitoring 1
Symptomatic Patients
- Antiplatelet therapy is recommended for all patients with subclavian artery stenosis to prevent ischemic events 1
- Revascularization is indicated for patients with:
Revascularization Options
Endovascular Treatment:
- Percutaneous angioplasty with stenting is recommended as first-line therapy for patients at high risk for surgical complications 1
- Technical success rates are high (93-100%) for stenosis but lower (80-95%) for occlusions 1
- Primary patency rates at 1 year are approximately 93%, decreasing to 70% at 5 years 1
- Balloon-expandable stents are preferred for heavily calcified ostial lesions 1
- Periprocedural complication rates around 15% have been reported 1
Surgical Treatment:
- Extra-anatomic carotid-subclavian bypass is reasonable for symptomatic patients without high surgical risk 1
- Other surgical options include carotid-axillary bypass, axilloaxillary bypass, and subclavian-carotid arterial transposition 1
- Surgical approaches demonstrate excellent long-term patency (96-100% at 1 year, 96% at 5 years) 1
- Lower periprocedural complication rates (approximately 6%) compared to endovascular therapy 1
- Greater freedom from recurrent symptoms compared to endovascular therapy 1
Comparative Effectiveness and Decision-Making
No randomized trials have directly compared endovascular versus surgical revascularization 1
In non-randomized comparisons, surgical bypass has shown superior long-term patency and freedom from symptoms compared to endovascular therapy 1
A study comparing 121 patients with stenting versus 51 with carotid-subclavian bypass showed:
Combination therapy (antiplatelet drugs plus revascularization) has been associated with fewer cardiovascular adverse events (17% vs. 40%) and lower all-cause mortality (13% vs. 47%) compared to antiplatelet therapy alone 3
Clinical Pitfalls and Considerations
- Bilateral subclavian disease may present with symmetrical blood pressures, potentially leading to missed diagnosis 1
- Occlusive lesions may be technically challenging for endovascular therapy, with failure rates up to 30-48% reported in some series 4
- Complications of endovascular treatment can include thromboembolism, heart failure, arm edema, and arterial pseudoaneurysm 2
- In-stent restenosis can occur and may be treated with repeat angioplasty or stenting 5
- For right-sided subclavian artery stenosis, endovascular treatment requires greater technical skill due to the close proximity of the right subclavian artery origin to the vertebral and common carotid arteries 6